Skip to content

Electroacupuncture for Sciatica Due to Intervertebral Disc Displacement

Electroacupuncture for Sciatica Due to Intervertebral Disc Displacement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02087462
Enrollment
324
Registered
2014-03-14
Start date
2012-01-31
Completion date
2014-06-30
Last updated
2014-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatica Due to Intervertebral Disc Disorder

Keywords

Sciatica, Electroacupuncture, Intervertebral disc displacement

Brief summary

This multicenter randomized controlled trial (RCT) will evaluate the therapeutic effectiveness and health-economics of electroacupuncture for sciatica due to intervertebral disc displacement in 3 compared groups: electroacupuncture, electroacupuncture plus traction, electroacupuncture plus traction and medication.

Detailed description

This is a multicenter RCT with 3 groups to determine the effectiveness and health economic evaluation of the electroacupuncture for sciatica due to intervertebral disc displacement in a population of adults aged 18-65. 324 participants who meet the inclusion criteria will be randomly allocated into 3 different groups, namely electroacupuncture group, electroacupuncture & traction group, electroacupuncture & traction & oral medication group. All participants will receive six-week treatment, the participants in electroacupuncture group will receive electroacupuncture only, electroacupuncture & traction group will receive both electroacupuncture and traction, and in electroacupuncture & traction & oral medication group all of the three therapies are adopted. The statistical analysis will be conducted by a third party who is masked to the allocation of participants.

Interventions

Main acupoints: Da chang shu (BL25), Huan tiao (GB30), bilateral Jiaji point of attacked lumbar vertebra, Ashi points, modifying points according to different patterns. Electroacupuncture: choose the dilatational wave, frequency is 2Hz/100Hz, electric current ranges from 0.1mA to 1.0mA, 30 mins per time. Treatment frequency: 5 times per week in the first 2 weeks, 3 times per week in the 3rd and 4th week, 2 times per week in the 5th and 6th week. Duration: 6 weeks.

An electric pelvis traction in supine position will be applied. The treatment frequency and duration are the same as EA.

Medication: 50 mg, twice per day Treatment frequency: In the first 2 weeks, take medicine for continuous 5 days with a 2-day interval each week; in the 3rd and 4th week, take medicine every 2 days, totally 3 times each week; in the 5th and 6th week, take medicine every 3 days, totally 2 times each week. Duration: 6 weeks.

Medication: 10mg, twice per day. Treatment frequency: In the first 2 weeks, take medicine for continuous 5 days with a 2-day interval each week; in the 3rd and 4th week, take medicine every 2 days, totally 3 times each week; in the 5th and 6th week, take medicine every 3 days, totally 2 times each week. Duration: 6 weeks.

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients who meet the clinical diagnosis of sciatica caused by intervertebral disc displacement; * Male or female, aged 18-65; * Have completed informed consent form.

Exclusion criteria

* Patients with sciatica caused by diseases such as piriformis syndrome, thickening of ligamentum flavus, acute lumbar strain, contusion, congenital spina bifid, lumbar and sacrum deformity, lumbar sacral vertebra joint disorder or proliferative osteoarthrosis; * Patients with urinary and fecal incontinence caused by acute lumbar disc herniation, huge or central type lumbar disc herniation sufferer in need of surgery; * Patients who fail to finish the basic treatment course, or have poor adherence; * Patients having a poor state, particularly unconsciousness, psychopath, severe osteoporosis, concurrent infection or bleeding susceptibly, or accompany with primary diseases in cardiovascular, digestion or hemopoietic systems and viscera as kidney, liver; * Pregnant or lactating women; * Patients in other clinical research.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale(VAS) of Leg PainChange from baseline in VAS of Leg Pain at 6 weeks

Secondary

MeasureTime frame
Simplified McGill Pain Questionnaire (ST-MPQ)Change from baseline in ST-MPQ at 6 weeks
Improved Roland Functional questionaire(RDQ)Change from baseline in RDQ at 6 weeks
Visual Analog Scale(VAS) of Low Back PainChange from baseline in VAS of Low Back Pain at 6 weeks
The Medical Outcomes Study 36-Item Short -Form Health Survey Questionnaire (SF-36)Change from baseline in SF-36 at 6 weeks
Sciatica Frequency and Bothersome Index (SFBI)Change from baseline in SFBI at 6 weeks
Likert Overall Recovery Self Rating Scale (7 points)Change from baseline in Likert Overall Recovery Self Rating Scale at 6 weeks

Countries

China

Contacts

Primary ContactXi Wu, A.P.
wuxi403@hotmail.com86-15928830710

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026